Similar Articles
1241 Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection
1242 Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma
1243 Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome
1244 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
1245 Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma
1246 Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment
1247 Hepatitis B viral load affects prognosis of hepatocellular carcinoma
1248 Characterization of monocarboxylate transporter activity in hepatocellular carcinoma
1249 Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy
1250 Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: Past, present and future
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA